These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6012642)

  • 21. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
    Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pleural effusion of gout].
    Zhang K; Liu L; Han Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jun; 23(6):361-2. PubMed ID: 11778520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renal lesions in uric arthritis].
    Guceva-Dajlevska B; Pusevski A; Grlickov M; Cakaloroska D; Nada M
    God Zb Med Fak Skopje; 1977; 23():919-24. PubMed ID: 615061
    [No Abstract]   [Full Text] [Related]  

  • 25. [Uric acid and tubulointerstitial kidney diseases].
    Wrenger E; Bahlmann J; Floege J
    Internist (Berl); 1996 Nov; 37(11):1137-42. PubMed ID: 9036109
    [No Abstract]   [Full Text] [Related]  

  • 26. [Kidney function in gout patients based on N-acetyl-beta-D glucosaminidase, human serum albumin and beta-2 microglobulin levels].
    Poór G; Jósfay L; Falus A; Mituszova M
    Orv Hetil; 1981 Aug; 122(33):2012-4. PubMed ID: 7031559
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical aspects of nephropathy in gout (based on 210 cases of gout)].
    Kawenoki-Minc E; Eyman E; Weryńska-Przybylska J; Abgarowicz T
    Reumatologia; 1974; 12(4):355-66. PubMed ID: 4445617
    [No Abstract]   [Full Text] [Related]  

  • 28. Azapropazone or allopurinol in the treatment of chronic gout and/or hyperuricaemia. A preliminary report.
    Templeton JS
    Br J Clin Pract; 1982 Oct; 36(10):353-8. PubMed ID: 7171423
    [No Abstract]   [Full Text] [Related]  

  • 29. [Personal experience of urate lithiasis (author's transl)].
    Bollack C; Reinhardt W; Goldschmidt P; D'Ancona C
    J Urol (Paris); 1981; 87(4):231-3. PubMed ID: 7264353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dyslipoproteinemia and hyperuricemia in podagra and urinary calculi].
    Barats IS
    Ter Arkh; 1982; 54(10):52-4. PubMed ID: 7179120
    [No Abstract]   [Full Text] [Related]  

  • 31. [An epidemiologic study on pathogenesis of uric acid urolithiasis].
    Okabe H; Hosoya T; Ichida K; Tabe A; Saji M; Hikita M; Sakai O
    Ryumachi; 1995 Oct; 35(5):773-9. PubMed ID: 8594656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extraarticular diseases and findings in gout].
    Heidelmann G; Thiele P; Schröder HE
    Z Gesamte Inn Med; 1982 Jul; 37(13):410-6. PubMed ID: 7136080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal lithiasis in gout].
    SOLIANI F
    Rass Clin Sci; 1961 Dec; 37():347-9. PubMed ID: 13914946
    [No Abstract]   [Full Text] [Related]  

  • 35. Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases.
    Rozenberg S; Roche B; Dorent R; Koeger AC; Borget C; Wrona N; Bourgeois P
    Rev Rhum Engl Ed; 1995 May; 62(5):392-4. PubMed ID: 7655872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Female gout: clinical and laboratory features.
    De Souza A; Fernandes V; Ferrari AJ
    J Rheumatol; 2005 Nov; 32(11):2186-8. PubMed ID: 16265700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Different variants of kidney lesions in gout].
    Matiashvili MG
    Arkh Patol; 1983; 45(6):73-6. PubMed ID: 6625932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Attempt at normalizing the uricemia in gout].
    Piliaev VG
    Vrach Delo; 1980 Apr; (4):88-90. PubMed ID: 7385782
    [No Abstract]   [Full Text] [Related]  

  • 40. [Kidney function in gout].
    Vukotić D; Pilipović N
    Med Pregl; 1979; 32(5-6):223-7. PubMed ID: 481339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.